Janux Therapeutics Inc (JANX)
29.12 x 1 35.09 x 2
Post-market by (Cboe BZX)
30.83 -0.91 (-2.87%) 03/25/25 [NASDAQ]
29.12 x 1 35.09 x 2
Post-market 30.83 unch (unch) 16:26 ET
for Tue, Mar 25th, 2025
Fiscal Year End Date: 12/31
12-2019 | 12-2017 | 12-2006 | 12-2005 | 12-2000 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 658 | N/A | N/A | N/A | N/A |
Other current assets | 0 | 0 | 0 | 0 | 10 |
TOTAL | $658 | $N/A | $N/A | $N/A | $10 |
Non-Current Assets | |||||
PPE Net | 21 | N/A | N/A | N/A | N/A |
TOTAL | $21 | $N/A | $N/A | $N/A | $N/A |
Total Assets | $679 | $N/A | $N/A | $N/A | $10 |
Liabilities | |||||
Current Liabilities | |||||
Accounts payable and accrued liabilities | 267 | 0 | 0 | 0 | 1,360 |
Accrued Expenses | 360 | N/A | N/A | N/A | 1,060 |
Other current liabilities | N/A | N/A | N/A | N/A | 1,600 |
TOTAL | $4,627 | $N/A | $N/A | $N/A | $4,590 |
Non-Current Liabilities | |||||
TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
Total Liabilities | $4,627 | $N/A | $N/A | $N/A | $4,590 |
Shareholders' Equity | |||||
Common Shares | 1 | N/A | N/A | N/A | 16,280 |
Retained earnings | -7,955 | N/A | N/A | N/A | N/A |
Other shareholders' equity | 3,996 | 0 | 0 | 0 | 7,040 |
TOTAL | $-3,948 | $N/A | $N/A | $N/A | $20,870 |
Total Liabilities And Equity | $679 | $0 | $0 | $0 | $25,460 |